NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 02 04:00PM ET
30.16
Dollar change
-0.44
Percentage change
-1.44
%
Index- P/E32.22 EPS (ttm)0.94 Insider Own0.10% Shs Outstand437.52M Perf Week0.87%
Market Cap13.20B Forward P/E13.75 EPS next Y2.19 Insider Trans0.00% Shs Float437.07M Perf Month3.46%
Enterprise Value15.90B PEG2.63 EPS next Q- Inst Own7.20% Short Float0.57% Perf Quarter6.99%
Income410.01M P/S2.28 EPS this Y14.90% Inst Trans-1.04% Short Ratio2.77 Perf Half Y21.66%
Sales5.78B P/B2.50 EPS next Y13.19% ROA4.03% Short Interest2.48M Perf YTD22.70%
Book/sh12.05 P/C21.32 EPS next 5Y12.24% ROE7.82% 52W High31.72 -4.92% Perf Year21.71%
Cash/sh1.41 P/FCF22.00 EPS past 3/5Y-7.56% -7.22% ROIC4.81% 52W Low23.69 27.31% Perf 3Y5.97%
Dividend Est.0.80 (2.65%) EV/EBITDA10.61 Sales past 3/5Y3.69% 2.49% Gross Margin69.64% Volatility1.01% 1.25% Perf 5Y-19.94%
Dividend TTM0.75 (2.49%) EV/Sales2.75 EPS Y/Y TTM55.99% Oper. Margin14.83% ATR (14)0.50 Perf 10Y-13.41%
Dividend Ex-DateMar 28, 2025 Quick Ratio1.33 Sales Y/Y TTM4.58% Profit Margin7.09% RSI (14)58.69 Recom2.05
Dividend Gr. 3/5Y-0.46% -0.28% Current Ratio2.89 EPS Q/Q116.64% SMA201.29% Beta0.71 Target Price33.01
Payout76.28% Debt/Eq0.63 Sales Q/Q5.74% SMA504.55% Rel Volume0.61 Prev Close30.60
Employees18456 LT Debt/Eq0.62 EarningsFeb 25 BMO SMA20010.06% Avg Volume894.31K Price30.16
IPONov 16, 1999 Option/ShortYes / Yes EPS/Sales Surpr.1.92% 0.70% Trades Volume543,734 Change-1.44%
Date Action Analyst Rating Change Price Target Change
Apr-25-25Downgrade HSBC Securities Buy → Hold
Mar-12-25Downgrade UBS Buy → Neutral
Nov-06-24Downgrade Berenberg Buy → Hold
Nov-01-24Downgrade Deutsche Bank Buy → Hold
Jul-24-24Initiated Deutsche Bank Buy
Jun-05-24Upgrade UBS Neutral → Buy
Nov-28-23Upgrade Barclays Underweight → Equal Weight
Nov-03-23Upgrade JP Morgan Neutral → Overweight
Oct-31-23Upgrade HSBC Securities Hold → Buy
Oct-13-23Initiated Stifel Hold
Jun-29-25 07:00AM
Jun-26-25 10:55AM
Jun-25-25 11:40AM
09:40AM
Jun-24-25 10:00AM
08:00AM Loading…
Jun-23-25 08:00AM
Jun-20-25 11:40AM
Jun-18-25 04:00AM
Jun-09-25 10:00AM
May-27-25 10:00AM
May-14-25 08:00AM
May-07-25 08:00AM
May-05-25 02:00AM
May-02-25 05:42PM
Apr-30-25 11:58PM
04:30PM Loading…
Apr-29-25 04:30PM
09:40AM
06:24AM
Apr-19-25 10:09PM
Apr-08-25 07:38PM
Apr-01-25 10:02AM
Mar-11-25 11:00AM
Mar-10-25 11:00AM
Mar-06-25 10:00AM
Mar-05-25 11:21AM
Mar-04-25 09:00AM
Feb-26-25 02:01AM
Feb-25-25 09:01PM
Feb-16-25 06:00PM
Feb-11-25 10:53PM
10:00AM Loading…
Feb-03-25 10:00AM
Jan-14-25 08:00AM
Dec-30-24 06:04AM
Dec-29-24 04:20AM
Dec-19-24 10:00AM
Dec-16-24 10:00AM
Dec-06-24 11:18AM
Oct-31-24 03:49PM
12:27PM
Oct-16-24 09:00AM
Oct-14-24 09:26AM
Oct-09-24 08:00AM
Oct-02-24 08:00AM
Sep-25-24 04:54PM
Sep-18-24 10:00AM
Sep-12-24 10:57AM
Sep-11-24 08:30AM
Sep-10-24 10:00AM
Aug-12-24 11:21AM
Aug-07-24 01:10PM
Aug-01-24 04:05PM
Jul-30-24 08:00AM
Jul-24-24 09:40AM
Jul-17-24 12:27PM
Jul-16-24 08:00AM
Jul-12-24 08:13AM
Jul-10-24 08:07PM
Jul-09-24 08:00AM
Jul-08-24 08:26PM
12:34PM
11:16AM
Jul-04-24 01:40PM
01:05PM
Jun-27-24 02:47PM
Jun-26-24 03:00AM
Jun-14-24 01:34PM
Jun-12-24 08:00AM
Jun-08-24 10:08PM
May-20-24 06:00AM
Apr-18-24 07:00AM
Apr-11-24 09:15AM
Apr-08-24 06:00PM
11:27AM
Apr-04-24 11:13AM
Apr-01-24 08:00AM
07:06AM
Mar-25-24 08:00AM
Mar-13-24 04:30PM
Feb-28-24 12:52PM
10:21AM
08:00AM
Feb-27-24 05:09PM
05:04PM
04:19PM
02:42AM
Feb-21-24 09:40AM
Feb-13-24 08:00AM
Feb-12-24 03:00PM
08:00AM
Feb-10-24 12:03PM
Jan-24-24 09:40AM
Jan-18-24 08:38PM
Jan-14-24 04:00PM
Jan-11-24 07:00AM
Nov-28-23 11:31AM
Nov-27-23 01:33AM
Nov-03-23 06:25PM
Oct-11-23 02:00AM
Oct-05-23 07:06AM
Oct-03-23 05:02AM
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.